Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 1 6Phase 3 4Phase 1/2 4Phase NA 1Phase 4 1

Status

Completed 3Recruiting 1

Sponsor Class

INDUSTRY 8OTHER 4NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 2Gynecologic 2

Conditions

Sarcoma 2Ovarian Neoplasms 2

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 166Gemcitabine 165Oxaliplatin 162Carboplatin 160Paclitaxel 152Leucovorin 122Drug Therapy 118Dexamethasone 118Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 56Neoadjuvant Therapy 53Lenalidomide 52Letrozole 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Trabectedin × Clear all
NCT05597917 2025-04-04

TRABTRAP

Universität Münster

Phase 3 Recruiting
126 enrolled
Sarcoma

Sarcoma

NCT01379989 2022-02-09

INOVATYON

Mario Negri Institute for Pharmacological Research

Phase 3 Completed
617 enrolled
Gynecologic

Ovarian Neoplasms

NCT02903004 2021-08-25

MITO23

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 3 Completed
242 enrolled
Gynecologic

Ovarian Neoplasms

NCT02672527 2018-08-16

TSAR

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed
103 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡